BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 25854439)

  • 1. Heart rate and B-blockade in stable coronary artery disease in Greece.
    Sbarouni E; Voudris V; Georgiadou P; Hamilos M; Steg G; Fox KM; Greenlaw N; Vardas PE;
    Hellenic J Cardiol; 2015; 56(2):112-7. PubMed ID: 25854439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heart rate and the use of beta-blockers in stable outpatients with coronary artery disease: Polish baseline results of the CLARIFY registry.
    Stępińska J; Marona M; Greenlaw N; Steg G;
    Kardiol Pol; 2014; 72(11):1156-64. PubMed ID: 25001472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heart rate and use of beta-blockers in stable outpatients with coronary artery disease.
    Steg PG; Ferrari R; Ford I; Greenlaw N; Tardif JC; Tendera M; Abergel H; Fox KM;
    PLoS One; 2012; 7(5):e36284. PubMed ID: 22570699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Status of β-blocker use and heart rate control in Chinese patients with stable coronary artery disease].
    Sun Y; Yu J; Hu D;
    Zhonghua Xin Xue Guan Bing Za Zhi; 2016 Jan; 44(1):19-26. PubMed ID: 26813548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inadequate heart rate control is associated with worse quality of life in patients with coronary artery disease and chronic obstructive pulmonary disease. The RYTHMOS study.
    Andrikopoulos G; Pastromas S; Kartalis A; Toli K; Mantas I; Tzeis S; Kyrpizidis C; Olympios C; Manolis AJ; Foussas S; Kranidis A; Pras A; Pipilis A; Chryssos D; Gotsis A; Trikas A; Richter D; Alexopoulos D; Parthenakis F; Theodorakis G; Konstantinides S; Vardas P
    Hellenic J Cardiol; 2012 Mar; 53(2):118-26. PubMed ID: 22484777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inadequate heart rate control despite widespread use of beta-blockers in outpatients with stable CAD: findings from the international prospective CLARIFY registry.
    Tendera M; Fox K; Ferrari R; Ford I; Greenlaw N; Abergel H; Macarie C; Tardif JC; Vardas P; Zamorano J; Gabriel Steg P;
    Int J Cardiol; 2014 Sep; 176(1):119-24. PubMed ID: 25042656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical presentation and management of stable coronary artery disease: insights from the international prospective CLARIFY registry - results from the Greek national cohort.
    Sbarouni E; Voudris V; Georgiadou P; Hamilos M; Steg PG; Fox KM; Greenlaw N; Ferrari R; Vardas PE
    Hellenic J Cardiol; 2014; 55(6):442-7. PubMed ID: 25432195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heart rate and use of β-blockers in Mexican stable outpatients with coronary artery disease.
    Alcocer-Gamba MA; Martínez-Sánchez C; Verdejo-Paris J; Ferrari R; Fox K; Greenlaw N; Steg Philippe G;
    Arch Cardiol Mex; 2015; 85(4):270-7. PubMed ID: 25921309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of outpatients in France with stable coronary artery disease. Findings from the prospeCtive observational LongitudinAl RegIstry oF patients with stable coronary arterY disease (CLARIFY) registry.
    Danchin N; Ferrieres J; Guenoun M; Cattan S; Rushton-Smith SK; Greenlaw N; Ferrari R; Steg PG;
    Arch Cardiovasc Dis; 2014; 107(8-9):452-61. PubMed ID: 25128934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heart rate control in an unselected consecutive population of outpatients with stable coronary artery disease: Analysis of the CARDIf Study Cohort.
    Vitale C; Iellamo F; Volterrani M; Lombardi M; Fini M; Banach M; Rosano GM
    Angiology; 2010 Nov; 61(8):763-7. PubMed ID: 20462892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management and clinical outcome of stable coronary artery disease in Austria : Results from 5 years of the CLARIFY registry.
    Lang IM; Badr-Eslam R; Greenlaw N; Young R; Steg PG
    Wien Klin Wochenschr; 2017 Dec; 129(23-24):879-892. PubMed ID: 28913755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of an ambulatory population with stable coronary artery disease and importance of heart rate: the PULSAR registry.
    Seabra-Gomes R;
    Rev Port Cardiol; 2010 Apr; 29(4):483-508. PubMed ID: 20734572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rationale, design, and baseline characteristics of the CLARIFY registry of outpatients with stable coronary artery disease.
    Sorbets E; Greenlaw N; Ferrari R; Ford I; Fox KM; Tardif JC; Tendera M; Steg PG;
    Clin Cardiol; 2017 Oct; 40(10):797-806. PubMed ID: 28561986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gender- and age-related differences in clinical presentation and management of outpatients with stable coronary artery disease.
    Ferrari R; Abergel H; Ford I; Fox KM; Greenlaw N; Steg PG; Hu D; Tendera M; Tardif JC;
    Int J Cardiol; 2013 Sep; 167(6):2938-43. PubMed ID: 22985742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insufficient control of heart rate in stable coronary artery disease patients in Latvia.
    Balode I; Mintāle I; Latkovskis G; Jēgere S; Narbute I; Bajāre I; Greenlaw N; Steg PG; Ferrari R; Ērglis A;
    Medicina (Kaunas); 2014; 50(5):295-302. PubMed ID: 25488166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of anginal symptoms and myocardial ischemia and their effect on clinical outcomes in outpatients with stable coronary artery disease: data from the International Observational CLARIFY Registry.
    Steg PG; Greenlaw N; Tendera M; Tardif JC; Ferrari R; Al-Zaibag M; Dorian P; Hu D; Shalnova S; Sokn FJ; Ford I; Fox KM;
    JAMA Intern Med; 2014 Oct; 174(10):1651-9. PubMed ID: 25110899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of heart rate in cardiovascular diseases: how the results of the BEAUTIFUL study change clinical practice.
    Bruguera Cortada J; Varela A
    Am J Cardiovasc Drugs; 2009; 9 Suppl 1():9-12. PubMed ID: 20000882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. β-Blocker use and clinical outcomes in stable outpatients with and without coronary artery disease.
    Bangalore S; Steg G; Deedwania P; Crowley K; Eagle KA; Goto S; Ohman EM; Cannon CP; Smith SC; Zeymer U; Hoffman EB; Messerli FH; Bhatt DL;
    JAMA; 2012 Oct; 308(13):1340-9. PubMed ID: 23032550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Metoprolol Succinate in Patients with Stable Angina and Elevated Heart Rate Receiving Low-Dose β-Blocker Therapy.
    Jiang J; Cong H; Zhang Y; Li Z; Tao G; Li X; Qing L; Tan N; Zhao Z; Dong Y; Ji Z; Chen Y; Ge J; He B; Sun Y; Cao K; Huo Y
    Int J Med Sci; 2017; 14(5):477-483. PubMed ID: 28539824
    [No Abstract]   [Full Text] [Related]  

  • 20. Distribution of left ventricular ejection fraction and heart rate values in a cohort of stable coronary patients: the INDYCE registry.
    Tabet JY; Malergue MC; Guenoun M; Paganelli F; Meurin P; Not D; Jourdain P; Guedj-Meynier D;
    Arch Cardiovasc Dis; 2010; 103(6-7):354-62. PubMed ID: 20800799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.